RSLS - ReShape Lifesciences Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS-2,226-945N/AN/A
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate350k1.47M4.68M10.07M
Low Estimate1.24M1.47M4.68M10.07M
High Estimate1.24M1.47M4.68M10.07M
Year Ago Sales360k794k1.29M4.68M
Sales Growth (year/est)-2.80%85.10%263.60%115.20%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-609-315-525-250.6
EPS Actual-2,226-945-756-672
Difference-1,617-630-231-421.4
Surprise %-265.50%-200.00%-44.00%-168.20%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate0000
7 Days Ago-1.47-1.24-9.15-4.01
30 Days Ago-1.47-1.24-9.15-4.01
60 Days Ago-1.47-1.24-9.15-4.01
90 Days Ago-1.47-1.24-9.15-4.01
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRSLSIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.44
Next Qtr.N/AN/AN/A0.29
Current YearN/AN/AN/A0.20
Next YearN/AN/AN/A0.08
Next 5 Years (per annum)0.24%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A